Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Cytotherapy. 2024 Nov;26(11):1400-1410. doi: 10.1016/j.jcyt.2024.06.007. Epub 2024 Jun 12.
The prevalence of chronic wounds continues to be a burden in human medicine. Methicillin-resistant Staphylococcus aureus (MRSA) is commonly isolated from infected wounds. MRSA infections primarily delay healing by impairing local immune cell functions. This study aimed to investigate the potential of mesenchymal stromal cell (MSC)-secreted bioactive factors, defined as the secretome, to improve innate immune responses in vivo. MSCs were isolated from the bone marrow of horses, which serve as valuable translational models for wound healing. The MSC secretome, collected as conditioned medium (CM), was evaluated in vivo using mouse models of acute and MRSA-infected skin wounds.
Punch biopsies were used to create two full-thickness skin wounds on the back of each mouse. Acute wounds were treated daily with control medium or bone marrow-derived MSC (BM-MSC) CM. The antibiotic mupirocin was administered as a positive control for the MRSA-infected wound experiments. Wounds were photographed daily, and wound images were measured to determine the rate of closure. Trichrome staining was carried out to examine wound tissue histologically, and immunofluorescence antibody binding was used to assess immune cell infiltration. Wounds in the MRSA-infected model were swabbed for quantification of bacterial load.
Acute wounds treated with BM-MSC CM showed accelerated wound closure compared with controls, as illustrated by enhanced granulation tissue formation and resolution, increased vasculature and regeneration of hair follicles. This treatment also led to increased neutrophil and macrophage infiltration. Chronic MRSA-infected wounds treated with BM-MSC CM showed reduced bacterial load accompanied by better resolution of granulation tissue formation and increased infiltration of pro-healing M2 macrophages compared with control-treated infected wounds.
Collectively, our findings indicate that BM-MSC CM exerts pro-healing, immunomodulatory and anti-bacterial effects on wound healing in vivo, validating further exploration of the MSC secretome as a novel treatment option to improve healing of both acute and chronic wounds, especially those infected with antibiotic-resistant bacteria.
慢性伤口的患病率一直是人类医学的负担。耐甲氧西林金黄色葡萄球菌(MRSA)通常从感染的伤口中分离出来。MRSA 感染主要通过损害局部免疫细胞功能来延迟愈合。本研究旨在研究间充质基质细胞(MSC)分泌的生物活性因子(定义为分泌组)在体内改善固有免疫反应的潜力。从马的骨髓中分离出 MSC,马是伤口愈合的有价值的转化模型。将 MSC 分泌组(条件培养基,CM)作为收集物,在急性和 MRSA 感染皮肤伤口的小鼠模型中进行体内评估。
使用穿孔活检在每只小鼠的背部创建两个全层皮肤伤口。急性伤口每天用对照培养基或骨髓来源的 MSC(BM-MSC)CM 处理。抗生素莫匹罗星被用作 MRSA 感染伤口实验的阳性对照。每天拍摄伤口照片,并测量伤口图像以确定闭合率。进行三色染色以检查伤口组织的组织学,并使用免疫荧光抗体结合来评估免疫细胞浸润。对 MRSA 感染模型中的伤口进行拭子取样,以定量细菌负荷。
与对照相比,用 BM-MSC CM 处理的急性伤口显示出更快的伤口闭合,表现为增强的肉芽组织形成和解决、增加的血管生成和毛囊再生。这种治疗还导致中性粒细胞和巨噬细胞浸润增加。用 BM-MSC CM 处理的慢性 MRSA 感染伤口显示出较低的细菌负荷,与对照处理的感染伤口相比,肉芽组织形成的解决得到改善,促愈合 M2 巨噬细胞的浸润增加。
总之,我们的研究结果表明,BM-MSC CM 在体内对伤口愈合具有促愈、免疫调节和抗细菌作用,验证了进一步探索 MSC 分泌组作为改善急性和慢性伤口(特别是感染抗生素耐药菌的伤口)愈合的新治疗选择的合理性。